PHARM.ASPHARM.ASAMS
Loading
Asset Growth Under PressureDecelerating
Percentile Rank67
5Y CAGR-0.7%
Year-over-Year Change
Year-over-year total asset growth rate
5Y CAGR
-0.7%/yr
Long-term compound
Percentile
P67
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 6.17% |
| Q2 2025 | 10.68% |
| Q1 2025 | 0.80% |
| Q4 2024 | -6.00% |
| Q3 2024 | 2.30% |
| Q2 2024 | -5.83% |
| Q1 2024 | -6.22% |
| Q4 2023 | 7.90% |
| Q3 2023 | 1.55% |
| Q2 2023 | 1.61% |
| Q1 2023 | -0.66% |
| Q4 2022 | 11.37% |
| Q3 2022 | -2.94% |
| Q2 2022 | 0.28% |
| Q1 2022 | 12.05% |
| Q4 2021 | 0.00% |
| Q2 2021 | 0.85% |
| Q1 2021 | -2.52% |
| Q4 2020 | 11.78% |
| Q3 2020 | 5.13% |
| Q2 2020 | 6.39% |
| Q1 2020 | 31.13% |
| Q4 2019 | 5.81% |
| Q3 2019 | 3.25% |
| Q2 2019 | 4.41% |
| Q1 2019 | -8.69% |
| Q4 2018 | 9.61% |
| Q3 2018 | 6.79% |
| Q2 2018 | -0.35% |
| Q1 2018 | 5.54% |
| Q4 2017 | 21.33% |
| Q3 2017 | 13.14% |
| Q2 2017 | 3.41% |
| Q1 2017 | 5.34% |
| Q4 2016 | 143.27% |
| Q3 2016 | -8.18% |
| Q2 2016 | -5.56% |
| Q1 2016 | 0.24% |
| Q4 2015 | -9.84% |
| Q3 2015 | 24.32% |